MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
1672.08%
Quick Ratio
1672.08%
Cash Ratio
440.21%
Debt to Asset Ratio
7.25%
Unit: Thousand (K) dollars
Assets Breakdown
Marketable securities
Cash and cash equivalents
Litigation settlement receivable
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Noncontrolling interests
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
1,248,456
1,419,232
1,478,270
1,237,010
Marketable securities
2,593,626
2,872,601
3,051,708
3,148,825
Litigation settlement receivable
771,627
770,235
-
-
Other current assets
128,371
105,316
129,912
125,811
Total current assets
4,742,080
5,167,384
4,659,890
4,511,646
Property and equipment, net
11,320
11,986
13,447
25,667
Operating lease right-of-use assets
78,886
80,416
83,561
85,136
Investments measured at fair value
444,622
407,985
433,907
412,315
Other assets
29,585
40,916
34,563
27,834
Total assets
5,306,493
5,708,687
5,225,368
5,062,598
Accounts payable
25,084
18,002
13,294
15,064
Accrued expenses
168,740
205,823
117,991
108,315
Operating lease liabilities
12,384
11,147
10,436
9,002
Income tax payable
74,182
45,689
-
-
Other current liabilities
3,213
583
10,243
1,476
Total current liabilities
283,603
281,244
151,964
133,857
Liability instruments measured at fair value
-
0
0
33,269
Operating lease liabilities, noncurrent
94,768
96,291
98,503
89,844
Income tax payable, noncurrent
0
38,670
-
-
Other liabilities
6,253
70
677
170
Total liabilities
384,624
416,275
251,144
257,140
Additional paid-in capital
5,130,926
5,024,826
4,943,643
4,771,880
Accumulated deficit
-900,354
-501,814
-694,998
-429,107
Accumulated other comprehensive income
701
4,358
20,610
19,558
Shareholders equity attributable to roivant sciences ltd
4,231,273
4,527,370
4,269,255
4,362,331
Noncontrolling interests
690,596
765,042
704,969
443,127
Total shareholders equity
4,921,869
5,292,412
4,974,224
4,805,458
Total liabilities and shareholders equity
5,306,493
5,708,687
5,225,368
5,062,598
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Marketable securities
$2,593,626K
(-20.56%↓ Y/Y)
Cash and cash
equivalents
$1,248,456K
(0.81%↑ Y/Y)
Litigation settlement
receivable
$771,627K
Other current assets
$128,371K
(14.01%↑ Y/Y)
Total current assets
$4,742,080K
(2.74%↑ Y/Y)
Investments measured at fair
value
$444,622K
(56.66%↑ Y/Y)
Operating lease
right-of-use assets
$78,886K
(-9.41%↓ Y/Y)
Other assets
$29,585K
(-4.85%↓ Y/Y)
Property and equipment,
net
$11,320K
(-23.85%↓ Y/Y)
Total assets
$5,306,493K
(5.44%↑ Y/Y)
Total liabilities and
shareholders equity
$5,306,493K
(5.44%↑ Y/Y)
Total shareholders
equity
$4,921,869K
(2.20%↑ Y/Y)
Total liabilities
$384,624K
(77.49%↑ Y/Y)
Shareholders equity
attributable to roivant...
$4,231,273K
(-2.63%↓ Y/Y)
Noncontrolling interests
$690,596K
(46.85%↑ Y/Y)
Total current
liabilities
$283,603K
(149.07%↑ Y/Y)
Operating lease
liabilities, noncurrent
$94,768K
(4.96%↑ Y/Y)
Other liabilities
$6,253K
(2642.54%↑ Y/Y)
Accumulated deficit
-$900,354K
(-185.29%↓ Y/Y)
Additional paid-in capital
$5,130,926K
(10.48%↑ Y/Y)
Accrued expenses
$168,740K
(90.18%↑ Y/Y)
Income tax payable
$74,182K
Accounts payable
$25,084K
(117.18%↑ Y/Y)
Operating lease
liabilities
$12,384K
(31.72%↑ Y/Y)
Other current
liabilities
$3,213K
(-23.24%↓ Y/Y)
Accumulated other
comprehensive income
$701K
(-95.91%↓ Y/Y)
Buy us a coffee
ROIV_BIG copy-svg
Roivant Sciences Ltd. (ROIV)
ROIV_BIG copy-svg
Roivant Sciences Ltd. (ROIV)